Tourmaline Bio, Inc.
← Back to TRML Overview

Tourmaline Bio, Inc. (TRML)

Solvency & Capital Structure

Total Debt

$145K

Net Debt

-$239.1M

Tourmaline Bio, Inc. currently has $145K in total debt. Net debt is -$239.1M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

TRMLQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2025-06-300.000.24-0.24Net Cash0.270.1%
2025-03-310.000.25-0.25Net Cash0.290.1%
2024-12-310.000.26-0.26Net Cash0.310.1%
2024-09-300.000.28-0.28Net Cash0.330.1%
2024-06-300.000.29-0.29Net Cash0.340.1%
2024-03-310.000.29-0.29Net Cash0.360.1%
2023-12-310.000.20-0.20Net Cash0.210.2%
2023-09-300.000.15-0.15Net Cash0.150.4%
2023-06-300.000.09-0.09Net Cash0.090.5%
2023-03-310.000.17-0.16Net Cash0.170.7%
2022-12-310.000.01-0.01Net Cash0.015.5%
2022-09-300.000.19-0.19Net Cash0.211.5%
2022-06-300.000.21-0.20Net Cash0.221.5%
2022-03-310.000.23-0.22Net Cash0.241.4%
2021-12-310.000.24-0.24Net Cash0.250.0%
2021-09-300.000.25-0.25Net Cash0.260.0%
2021-06-300.000.27-0.27Net Cash0.270.0%
2021-03-310.000.14-0.14Net Cash0.140.0%
2020-12-310.000.15-0.15Net Cash0.150.0%